Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
Quick Stats
Jan 30, 202650.4
AI Score
HOLD0.51
Volume Ratio
Feb 12, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
AGIO Stock Summary
Last updated Jan 30, 2026
AGIO is currently trading at $27.44, positioned below its 200-day moving average of $34.13, suggesting bearish momentum. The stock has a 52-week range of $22.24 to $46.
Technical Analysis: The 50-day moving average stands at $27.6, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 45.483, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.085, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates AGIO at 50.4/100 with a HOLD recommendation.
AGIO (Agios Pharmaceuticals, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 45.483 |
| CMF (20) | 0.085 |
| ROC (10) | -1.295 |
| ADX (14) | 15.388 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.216 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -67.663 |
| MFI (14) | 45.502 |
AGIO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
AGIO Price vs Max Options Open Interest
AGIO Max Change In Options Open Interest
AGIO Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AGIO Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AGIO Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AGIO Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Agios Pharmaceuticals, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
AGIO Moving Averages Analysis
AGIO (Agios Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 27.91 |
| 20 | 27.95 |
| 30 | 27.42 |
| 50 | 27.6 |
| 100 | 34.03 |
| 200 | 34.13 |
AGIO Fundamental Analysis
| P/E (Forward) | 2.4655 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.7 billion |
| Earnings/Share ($) | -7.01 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -7.01 |
| EPS Estimate Next Year ($) | -6.5926 |
| WallStreet Target Price ($) | 36.75 |
| Most Recent Quarter |